Ubi US Holdings, LLC
Records under this name other than the patents Ubi US Holdings, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Ubi US Holdings, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,350,322 | Peptide Immunogens Targeting Interleukin 6 (IL-6) and Formulations Thereof for Immunotherapy of Diseases Impacted by IL-6 Dysregulation Formerly held In force · High confidence | In force | High confidence | |
| US 7,501,494 | Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection Term ended Term ended Sep 20, 2024 · USPTO record | Term ended | Term ended Sep 20, 2024 | USPTO record |
| US 7,872,110 | Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection Term ended Term ended Jan 15, 2023 · USPTO record | Term ended | Term ended Jan 15, 2023 | USPTO record |
| US 7,467,433 | Changing table with integrated diaper dispenser Lapsed on the fee record Ended Dec 23, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 23, 2012 | USPTO record |
| US 5,912,176 | Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV Term ended Term ended no later than Jun 15, 2019 · Low confidence | Term ended | Term ended no later than Jun 15, 2019 | Low confidence |
| US 5,961,976 | Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV Term ended Term ended no later than Oct 5, 2019 · Low confidence | Term ended | Term ended no later than Oct 5, 2019 | Low confidence |